Personalized Cancer Vaccines and Cellular Therapy in Solid Tumors

Personalized Cancer Vaccines and Cellular Therapy in Solid Tumors

Ask the Expert - A Year in Review: 2022 Research Updates for the Melanoma CommunityПодробнее

Ask the Expert - A Year in Review: 2022 Research Updates for the Melanoma Community

The roles of neoantigen peptides in personalized medicineПодробнее

The roles of neoantigen peptides in personalized medicine

Imugene's CEO Leslie Chong presents at the 2023 JP Morgan Healthcare Conference in San Francisco.Подробнее

Imugene's CEO Leslie Chong presents at the 2023 JP Morgan Healthcare Conference in San Francisco.

Personal Cancer Vaccines: Customized Treatment for Each PatientПодробнее

Personal Cancer Vaccines: Customized Treatment for Each Patient

Cell Therapy in the Treatment of Solid TumorsПодробнее

Cell Therapy in the Treatment of Solid Tumors

2020 Immuno Oncology Samantha Zaroff GenscriptПодробнее

2020 Immuno Oncology Samantha Zaroff Genscript

Lecture 10c: Cancer ImmunotherapyПодробнее

Lecture 10c: Cancer Immunotherapy

New potential applications for CAR T-cell therapyПодробнее

New potential applications for CAR T-cell therapy

Clinical Trials Targeting Glioblastoma Stem Cells - Parvinder Hothi, PhDПодробнее

Clinical Trials Targeting Glioblastoma Stem Cells - Parvinder Hothi, PhD

The 5 Revolutions in Cancer TreatmentПодробнее

The 5 Revolutions in Cancer Treatment

Targeting Tumor Mutations for Personalized Cancer ImmunotherapyПодробнее

Targeting Tumor Mutations for Personalized Cancer Immunotherapy

CD19 CAR T Cell Therapy for Pediatric ALL: The Seattle Children’s ExperienceПодробнее

CD19 CAR T Cell Therapy for Pediatric ALL: The Seattle Children’s Experience

Cancer Vaccines: Are we Closer?Подробнее

Cancer Vaccines: Are we Closer?

Addressing Cancer Clonal Heterogeneity: Developing Personalized Neoantigen-Based Cancer VaccinesПодробнее

Addressing Cancer Clonal Heterogeneity: Developing Personalized Neoantigen-Based Cancer Vaccines